title: Use of femoral venous catheters in critically ill adults: prospective study.
abstract: OBJECTIVE
  To determine the frequency of clinically important complications of femoral venous catheters.
  
  
  METHODS
  Prospective survey of major and minor complications.
  
  
  METHODS
  A mixed medical/surgical ICU in a university hospital.
  
  
  METHODS
  One hundred twenty-three patients admitted to the ICU who underwent femoral venous catheterization over a 2-yr period.
  
  
  RESULTS
  There were 150 catheters inserted in 123 patients for a mean duration of 6.4 days. There were no major complications including catheter-related sepsis. Minor complications consisted of arterial puncture (9.3%), local bleeding (10%), and local inflammation (4.7%). Critical care fellows had a significantly lower rate (6%) of insertion complications than interns or medical students (16%). We did not specifically look at the frequency of deep venous thrombosis.
  
  
  CONCLUSIONS
  Femoral venous catheterization offers an alternative site of insertion to the subclavian and jugular veins for central venous access in the critically ill. The occurrence rate of clinically important complications is acceptably low.
authors.affiliation: Department of Anesthesiology, George Washington University Medical Center, Washington, DC 20037.
authors.forename: J F
authors.initials: JF
authors.lastname: Williams
authors.forename: M G
authors.initials: MG
authors.lastname: Seneff
authors.forename: B C
authors.initials: BC
authors.lastname: Friedman
authors.forename: B J
authors.initials: BJ
authors.lastname: McGrath
authors.forename: R
authors.initials: R
authors.lastname: Gregg
authors.forename: J
authors.initials: J
authors.lastname: Sunner
authors.forename: J E
authors.initials: JE
authors.lastname: Zimmerman
mesh_terms: D000328:Adult; D001424:Bacterial Infections / Q000209:etiology; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003422:Critical Care / Q000379:methods; D005268:Femoral Vein; D006801:Humans; D011446:Prospective Studies; D013923:Thromboembolism / Q000209:etiology